A detailed history of London CO Of Virginia transactions in Eli Lilly & CO stock. As of the latest transaction made, London CO Of Virginia holds 23,799 shares of LLY stock, worth $18.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
23,799
Previous 24,605 3.28%
Holding current value
$18.9 Million
Previous $22.3 Million 5.35%
% of portfolio
0.11%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $622,344 - $773,776
-806 Reduced 3.28%
23,799 $21.1 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $513,207 - $643,600
-708 Reduced 2.8%
24,605 $22.3 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $179,089 - $211,123
-341 Reduced 1.33%
25,313 $14.8 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $942,429 - $1.3 Million
2,168 Added 9.23%
25,654 $13.8 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $633,685 - $744,232
-2,040 Reduced 7.99%
23,486 $8.07 Million
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $522,197 - $608,464
-1,624 Reduced 5.98%
25,526 $9.34 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $9,190 - $10,473
-31 Reduced 0.11%
27,150 $8.78 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $217,688 - $255,597
781 Added 2.96%
27,181 $8.81 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $51,631 - $64,165
220 Added 0.84%
26,400 $7.56 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $153,347 - $190,305
-682 Reduced 2.54%
26,180 $7.23 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $135,176 - $166,353
610 Added 2.32%
26,862 $6.21 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $296,168 - $366,831
-2,770 Reduced 9.54%
26,252 $3.45 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $1,329 - $1,551
-12 Reduced 0.04%
29,022 $3.22 Million
Q1 2019

May 14, 2019

SELL
$111.31 - $131.02 $40,516 - $47,691
-364 Reduced 1.24%
29,034 $3.77 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $1.04 Million - $1.17 Million
9,823 Added 50.18%
29,398 $3.4 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $51,086 - $63,849
595 Added 3.13%
19,575 $2.1 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $89 Million - $102 Million
-1,176,331 Reduced 98.41%
18,980 $1.62 Million
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $197 Million - $233 Million
-2,658,463 Reduced 68.98%
1,195,311 $92.5 Million
Q4 2017

Feb 13, 2018

SELL
$81.94 - $87.89 $20.9 Million - $22.5 Million
-255,455 Reduced 6.22%
3,853,774 $325 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $317 Million - $352 Million
4,109,229
4,109,229 $352 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track London CO Of Virginia Portfolio

Follow London CO Of Virginia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London CO Of Virginia, based on Form 13F filings with the SEC.

News

Stay updated on London CO Of Virginia with notifications on news.